<div>Amy S. Paller, MD, principal investigator of the phase 3 LIBERTY AD PEDS trial, discusses the add-on biologic's benefit for young patients and potential as a pediatrc allergic therapy.</div>

Amy S. Paller, MD, principal investigator of the phase 3 LIBERTY AD PEDS trial, discusses the add-on biologic's benefit for young patients and potential as a pediatrc allergic therapy.

Dupilumab for Severe Pediatric Atopic Dermatitis

<div>Your destination feed for medical, health care and clinical science podcasts courtesy of HCPLive—featuring our shows Medical Ethics Unpacked, New Insight, and 5 Stories in Under 5.<br>
<br>
<br>
<br>

</div>

News

Science

Medicine

Health & Fitness

Business News

Life Sciences

Your destination feed for medical, health care and clinical science podcasts courtesy of HCPLive—featuring our shows Medical Ethics Unpacked, New Insight, and 5 Stories in Under 5.

Your destination feed for medical, health care and clinical science podcasts courtesy of HCPLive—featuring our shows Medical Ethics Unpacked, New Insight, and 5 Stories in Under 5.<br>
<br>
<br>
<br>



Share Dupilumab for Severe Pediatric Atopic Dermatitis

Sign up to save your podcasts

Dupilumab for Severe Pediatric Atopic Dermatitis

Dupilumab for Severe Pediatric Atopic Dermatitis

More shows like HCPLive Podcasts

Evidence-Based GI: An ACG Publication and Podcast